Phase I trial of proteasome inhibition with bortezomib (BOR) with concurrent chemoradiation (chemoXRT) for stage III non-small cell lung cancer (NSCLC)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7300-7300
Author(s):  
M. Suntharalingam ◽  
M. J. Edelman ◽  
K. Kwong ◽  
R. Smith ◽  
M. Bedor
2008 ◽  
Vol 3 (9) ◽  
pp. 1003-1011 ◽  
Author(s):  
Nicholas W. Choong ◽  
Ann M. Mauer ◽  
Daniel J. Haraf ◽  
Eric Lester ◽  
Philip C. Hoffman ◽  
...  

2011 ◽  
Vol 80 (1) ◽  
pp. 126-132 ◽  
Author(s):  
Sacha Rothschild ◽  
Stephan E. Bucher ◽  
Jacques Bernier ◽  
Daniel M. Aebersold ◽  
Aberrahim Zouhair ◽  
...  

Lung Cancer ◽  
1997 ◽  
Vol 18 ◽  
pp. 74 ◽  
Author(s):  
D. Lau ◽  
D. Gandara ◽  
J. Ryu ◽  
R. Morgan ◽  
J. Doroshow ◽  
...  

2012 ◽  
Vol 7 (11) ◽  
pp. 1683-1690 ◽  
Author(s):  
David R. Jones ◽  
Christopher A. Moskaluk ◽  
Heidi H. Gillenwater ◽  
Gina R. Petroni ◽  
Sandra G. Burks ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document